Li Bo, Nowak Nicola M, Kim Soo-Kyung, Jacobson Kenneth A, Bagheri Ali, Schmidt Clarice, Wess Jürgen
Department of Molecular Signaling, Laboratory of Bioorganic Chemistry, NIDDK, National Institutes of Health, 8 Center Dr., Bethesda, MD 20892, USA.
J Biol Chem. 2005 Feb 18;280(7):5664-75. doi: 10.1074/jbc.M411623200. Epub 2004 Nov 30.
The M(3) muscarinic receptor is a prototypical member of the class A family of G protein-coupled receptors (GPCRs). To gain insight into the structural mechanisms governing agonist-mediated M(3) receptor activation, we recently developed a genetically modified yeast strain (Saccharomyces cerevisiae) which allows the efficient screening of large libraries of mutant M(3) receptors to identify mutant receptors with altered/novel functional properties. Class A GPCRs contain a highly conserved Asp residue located in transmembrane domain II (TM II; corresponding to Asp-113 in the rat M(3) muscarinic receptor) which is of fundamental importance for receptor activation. As observed previously with other GPCRs analyzed in mammalian expression systems, the D113N point mutation abolished agonist-induced receptor/G protein coupling in yeast. We then subjected the D113N mutant M(3) receptor to PCR-based random mutagenesis followed by a yeast genetic screen to recover point mutations that can restore G protein coupling to the D113N mutant receptor. A large scale screening effort led to the identification of three such second-site suppressor mutations, R165W, R165M, and Y250D. When expressed in the wild-type receptor background, these three point mutations did not lead to an increase in basal activity and reduced the efficiency of receptor/G protein coupling. Similar results were obtained when the various mutant receptors were expressed and analyzed in transfected mammalian cells (COS-7 cells). Interestingly, like Asp-113, Arg-165 and Tyr-250, which are located at the cytoplasmic ends of TM III and TM V, respectively, are also highly conserved among class A GPCRs. Our data suggest a conformational link between the highly conserved Asp-113, Arg-165, and Tyr-250 residues which is critical for receptor activation.
M3毒蕈碱受体是G蛋白偶联受体(GPCRs)A类家族的典型成员。为深入了解激动剂介导的M3受体激活的结构机制,我们最近开发了一种基因改造的酵母菌株(酿酒酵母),它能够高效筛选突变型M3受体的大型文库,以鉴定具有改变/新功能特性的突变受体。A类GPCRs在跨膜结构域II(TM II;对应于大鼠M3毒蕈碱受体中的Asp-113)中含有一个高度保守的Asp残基,这对受体激活至关重要。如先前在哺乳动物表达系统中分析的其他GPCRs中所观察到的,D113N点突变消除了酵母中激动剂诱导的受体/G蛋白偶联。然后,我们对D113N突变型M3受体进行基于PCR的随机诱变,随后进行酵母遗传筛选,以恢复能够使G蛋白与D113N突变受体偶联的点突变。大规模筛选工作导致鉴定出三个这样的第二位点抑制突变,即R165W、R165M和Y250D。当在野生型受体背景中表达时,这三个点突变不会导致基础活性增加,反而降低了受体/G蛋白偶联的效率。当在转染的哺乳动物细胞(COS-7细胞)中表达和分析各种突变受体时,也获得了类似的结果。有趣的是,分别位于TM III和TM V细胞质末端的Arg-165和Tyr-250,与Asp-113一样,在A类GPCRs中也高度保守。我们的数据表明,高度保守的Asp-113、Arg-165和Tyr-250残基之间存在构象联系,这对受体激活至关重要。